Skip to site menu Skip to page content

Daily Newsletter

28 November 2024

Daily Newsletter

28 November 2024

DeepSight to unveil NeedleVue LiteCart system for ultrasound-guided procedures

The system is engineered to provide real-time visualisation of needles, guidewires and catheters without the need for radiation.

gullapalli November 27 2024

DeepSight Technology is set to unveil the ‘NeedleVue LiteCart Ultrasound System’ at the forthcoming Radiological Society of North America (RSNA) annual meeting.

At this event, the company expects to secure interest from clinicians willing to partner on clinical research for assessing the device.

NeedleVue is a new ultrasound-guided needle technology that aims to improve precision and confidence during medical procedures. It is engineered to provide real-time visualisation of needles, guidewires, and catheters without the need for radiation or complex calibration.

It is set to simplify and democratise interventional procedures by embedding tiny sensors at the tip of various instruments. The device is set to simplify procedures, allowing clinicians to perform with increased confidence and precision.

This self-calibrating technology requires no advanced setup and is compatible with free-hand procedural workflows.

Its non-electrical and inert design is unaffected by temperature and magnetic fields, making it suitable for abdominal procedures such as biopsies, and potentially across various medical specialities.

The system operates effectively even with contrast agents, providing comprehensive visibility within and outside the imaging plane.

DeepSight's NeedleVue marks a significant shift in needle guidance technology by providing real-time, precision needle tracking that is both portable and user-friendly, addressing the needs of healthcare providers for operational efficacy and optimised patient outcomes.

These features claim a paradigm shift in needle guidance technology, combining operational efficacy with optimised patient outcomes.

DeepSight Technology CEO and co-founder Nader Sadrzadeh said: "The potential applications for NeedleVue technology, including integrated solutions, are endless. NeedleVue aims to overcome existing limitations and represents the future of ultrasound-guided interventional procedures."

The NeedleVue LiteCart Ultrasound system has not yet received authorisation from the US Food and Drug Administration and is currently unavailable for sale or use.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close